AKT1 and anemia (phenotype): Integrated NP and LC-MS/MS analysis revealed SYD’s molecular mechanism for anemia: active components (ferulic acid, calycosin, and astragaloside A) act on the PI3K-Akt signaling pathway via AKT1, MAPK1, and MAPK14 [87].